Bangladesh parliamentary panel suggests suing Indian Covid vaccine maker

A parliamentary panel in Bangladesh has suggested filing a case against Serum Institute of India for failing to deliver the Covid vaccine on time despite an earlier commitment

May 11, 2021
Image
Covid vaccine (File)

A parliamentary panel in Bangladesh has suggested filing a case against Serum Institute of India for failing to deliver the Covid vaccine on time despite an earlier commitment.

 The parliamentary standing committee of the foreign ministry said the European Union has expressed its opinion on sueing the vaccine manufacturer.

The suggestion came at a committee meeting which held discussions on the vaccination situation in the country.

Bangladesh had signed an agreement with SII for delivery of Oxford-AstraZeneca vaccines from it, but the company failed to keep its commitment.

The meeting discussed the vaccination situation in the country.

“European Union has given an opinion to file a case against them (SII). We also have to consider filing a case since they failed to supply us the vaccine after receiving the money in advance,” chairman of the parliamentary committee Faruk Khan told Prothom Alo after the meeting.

The committee also suggested that the border with India  remain shut due to Covid situation in the neighboring country.

(SAM)

Newsletter Subscription

The subscriber's email address.
Stay informed - subscribe to our newsletter.
Tweets about SAMonitor
SAM Facebook

DMM Thank you